The early-2026 GLP-1 market stopped feeling stable almost overnight. Regulators sent warning letters to dozens of compounding-adjacent companies, Novo Nordisk’s March settlement moved several large platforms away from compounded semaglutide, and Lilly’s oral orforglipron rollout added a cheaper brand-name wrinkle.
That shakeout is actually useful. It made it easier to tell who has real infrastructure from who was riding a trend.
Here is where I landed after going through the pricing, pharmacy sourcing, and verification details on six services I’d genuinely consider.
1. HealthRX
The short reason this one sits at the top: the price-to-documentation ratio is better than anything else I found. Monthly pricing opens at $99 for compounded semaglutide and $149 for compounded tirzepatide. Those are among the lowest cash prices in this space, and the pharmacy behind the medication is not a black box. Manifest Pharmacy in Greer, South Carolina is a named 503A operation running under USP-797 standards with lot-tracked batches, and the service carries LegitScript certification (cert number 50087439 if you want to verify it yourself). Physician review typically happens within about 24 hours of your intake, and medication ships overnight to all 50 states at no added charge. The trial data HealthRX references is legitimate: the SURMOUNT-1 study showed roughly 21% average body weight reduction over 72 weeks for tirzepatide, and the STEP 1 trial showed about 15% over 68 weeks for semaglutide. Those are trial results, not guarantees from this or any provider.
Worth noting here: compounded medications are not FDA-approved products, regardless of how reputable the compounding pharmacy is. That applies to HealthRX and every other compounding-based service on this list.
2. FormBlends
FormBlends earns a spot because it solves a specific problem that most GLP-1 services don’t bother with: published analytical testing. They put out HPLC purity figures, mass spec identity results, and endotoxin and sterility data with named percentages per product. If you’re the kind of person who wants to read the actual numbers before injecting something, that matters. The pharmacy is an FDA-registered 503A compounder. The per-vial pricing runs higher than HealthRX, around $299 for semaglutide and $349 for tirzepatide. They also carry a broader peptide catalog covering recovery, longevity, and cognitive products under the same clinician model, which is genuinely unusual. One practical limitation: they currently ship to 47 states, not all 50.
If price is your primary filter, HealthRX wins cleanly. If published lab documentation or access to a wider peptide menu from one provider is more important to you, FormBlends is the better fit.
3. Mochi Health
Mochi has built its model around board-certified obesity-medicine clinicians rather than general practitioners, which means the provider reviewing your chart actually specializes in this area. Compounded semaglutide comes in at roughly $99 per month, with tirzepatide closer to $199. The monitoring is more structured than most cash-pay services, which appeals to patients who want more than a quick prescription and a shipping confirmation.
4. Hims & Hers
After the March 2026 Novo settlement, Hims & Hers moved away from compounded GLP-1s and shifted to branded medications. Injectable Wegovy is around $299 a month through them, oral semaglutide around $249, and Zepbound around $399. With insurance and applicable savings cards, some patients get to $0-25 a month. The brand recognition is real, and so is the customer-service infrastructure. But the cash-pay prices are substantially higher than the compounding-based services here.
5. Ro Body
Ro’s membership runs about $39 for the first month, then roughly $74-149 going forward, with medications billed separately. They have a prior-authorization team that works the insurance angle for branded meds, which is worth something if your plan covers GLP-1s and you don’t want to manage that process yourself.
6. Henry Meds
Henry is a cash-pay compounding option with fast shipping, typically 24-72 hours. First-month pricing lands around $179-249. The monitoring is lighter than Mochi’s, which means less friction for some patients and less oversight for others. Depends on what you’re looking for.
How I’d Actually Choose
Start with whether you want compounded or branded meds. If branded and insurance are your path, Hims & Hers or Ro make more sense. If you’re paying cash and want the lowest entry price with documented pharmacy sourcing, HealthRX is the practical starting point. If published purity testing matters more than price, FormBlends. If you want a specialist obesity-medicine clinician involved, Mochi. Simple as that.
Common Questions
Does HealthRX’s LegitScript certification actually mean anything for compounded semaglutide?
LegitScript certification confirms that a telehealth or pharmacy operation meets specific legal and operational standards, including licensed prescribers and compliant dispensing practices. It does not certify the compounded medication itself as FDA-approved. Cert number 50087439 is publicly searchable on LegitScript’s site, so you can verify HealthRX’s standing directly rather than taking anyone’s word for it.
After the March 2026 Novo Nordisk settlement, can services like HealthRX and FormBlends still legally compound semaglutide?
The settlement addressed specific compounders named in litigation, not all 503A pharmacies broadly. Whether a given compounder can continue depends on FDA shortage-list status and individual compliance with USP-797 standards. The regulatory picture has shifted and is still evolving, so checking the current FDA drug shortage database before subscribing is a practical step, not an optional one.
What is the real difference between Mochi Health’s clinician model and what Hims & Hers or Ro offer?
Mochi routes patients to board-certified obesity-medicine specialists. Hims & Hers and Ro use general telehealth providers who handle a wide range of conditions. For straightforward cases that’s often fine, but if you have a complex metabolic history or prior GLP-1 side effects, a specialist who focuses specifically on weight medicine may give you more useful clinical guidance.
FormBlends charges roughly $200 more per vial than HealthRX. What does that extra cost actually buy?
Primarily the published analytical testing: HPLC purity figures, mass spec identity confirmation, and endotoxin and sterility data with specific percentages listed per product batch. You’re also getting access to a broader peptide catalog from one provider. If you won’t read those lab documents, the price gap is hard to justify. If you will, it’s a legitimate reason to pay more.
How does Ro Body’s separate medication billing compare to all-in pricing from services like Henry Meds?
Ro separates its membership fee ($39 first month, then $74-149) from medication costs, so the total monthly spend depends heavily on which drug and dose you end up on. Henry Meds bundles everything into a single first-month figure of roughly $179-249. Neither model is inherently cheaper without knowing your specific prescription, so asking each service for an all-in monthly estimate before committing is worth the extra step.
Sources
- FDA warning letters to GLP-1 telehealth/compounding firms, early 2026 (FDA.gov enforcement announcements)
- Novo Nordisk compounding settlement, March 9 2026 (Novo Nordisk press release, Reuters reporting)
- SURMOUNT-1 tirzepatide trial results (Jastreboff et al., *New England Journal of Medicine*, 2022)
- STEP 1 semaglutide trial results (Wilding et al., *New England Journal of Medicine*, 2021)
- LillyDirect orforglipron launch pricing, April 2026 (Eli Lilly press materials)
- LegitScript pharmacy certification database (legitscript.com)
